DETAILED NOTES ON DO-264

Detailed Notes on DO-264

quinupristin/dalfopristin will improve the degree or outcome of bosentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.quinupristin/dalfopristin will improve the amount or impact of bazedoxifene/conjugated estrogens by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.quinupris

read more